Sorbolene

DRUG2 trials

Sponsors

Trans Tasman Radiation Oncology Group, Stratpharma AG

Conditions

Breast CancerRadiation Dermatitis

Phase 3

Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine (Sorbolene) Cream

CompletedNCT00193908

Trans Tasman Radiation Oncology GroupBreast Cancer

Start: 2004-03-31End: 2008-10-31Updated: 2009-05-14

Unknown Phase

StrataXRT vs. Standard Clinical Practice in the Prevention and Treatment of Radiation Dermatitis

CompletedNCT05450848

Stratpharma AGRadiation Dermatitis

Start: 2017-09-01End: 2023-03-31Updated: 2023-07-12